The Tsinghua University-backed hydrogen fuel engine producer has reportedly raised at least $67m of the $193m target for its initial public offering.

The Tunghsu, ZGC and BAIC-backed hydrogen fuel engine producer has reportedly raised at least $67m of the $193m target for its initial public offering.

Meituan Dianping and Bytedance were among the shareholders that committed to investing $380m in a concurrent private placement.

The creative digital studio has floated on TSE’s Mothers Market, enabling Kaga Electronics, Sony and Norinchukin Bank to exit.

Hefei Jianghang Aircraft Equipment has priced its shares at $1.48 each to raise $148m in an initial public offering that provided an exit to Aviation Industry Corporation.

CureVac has filed for an initial public offering in the US, 20 years after being spun out of Eberhard Karls University of Tübingen.

GlaxoSmithKline is in line for an exit as CureVac files for an initial public offering in the US, 20 years after being spun out of Eberhard Karls University of Tübingen.

Increasing both the number of shares and share price, iTeos Therapeutics has raised more than $201m in an offering that provided an exit to UCL and Ludwig Institute.

Nurix Therapeutics, a Celgene-backed cancer treatment developer based on UC Berkeley and San Francisco research, priced shares above its range to raise $209m.

Nurix Therapeutics, a Celgene-backed cancer treatment developer based on UC Berkeley and San Francisco research, priced shares above its range to raise $209m.